Steven J. Winick

Celmatix, Inc. operates as a personalized medicine company that focuses on women?s health. It offers POLARIS, a web-based analytics platform for optimizing a woman?s fertility; and NOVA, a patient portal that helps clinics to maximize the patient experience. Its products help women to make informed decisions about their fertility, as well as provide doctors with data-driven tools for patient care. The company was founded by Piraye Yurttas Beim and Laura Towart Bandak in 2009 and is headquartered New York, NY.

ThermoLift, Inc. is a company that is based in Stony Brook, NY. The company is an affiliate of Stony Brook University's Clean Energy Business Incubator Program (CEBIP) and is headquartered at the Advanced Energy Research and Technology Center (AERTC). ThermoLift's engineering, development, and testing center is located in Livonia, NY. The company's TC3 has been ranked #1 in the DOE report "Energy Savings Potential and RD&D Opportunities for Commercial Building HVAC Systems." The DOE provided funding, and performance testing was conducted by Oak Ridge National Labs. The TC3 has received an agency field label approval for installation in buildings. It was founded in 2012 by Peter Hofbauer and Paul Schwartz, and the CEO is David Parks.

ThermoLift, Inc. is a company that is based in Stony Brook, NY. The company is an affiliate of Stony Brook University's Clean Energy Business Incubator Program (CEBIP) and is headquartered at the Advanced Energy Research and Technology Center (AERTC). ThermoLift's engineering, development, and testing center is located in Livonia, NY. The company's TC3 has been ranked #1 in the DOE report "Energy Savings Potential and RD&D Opportunities for Commercial Building HVAC Systems." The DOE provided funding, and performance testing was conducted by Oak Ridge National Labs. The TC3 has received an agency field label approval for installation in buildings. It was founded in 2012 by Peter Hofbauer and Paul Schwartz, and the CEO is David Parks.

Codagenix, Inc. provides platform technology to construct viral vaccines against multiple targets. It focuses on SAVE platform technology that utilizes computer-based rational design of viral genomes for the design and construction of vaccines for a range of medically important human diseases. The company was founded by J. Robert Coleman, Eckard Wimmer, Charlie Petty and Steffen Mueller in 2009 and is headquartered in Farmingdale, NY.

Codagenix, Inc. provides platform technology to construct viral vaccines against multiple targets. It focuses on SAVE platform technology that utilizes computer-based rational design of viral genomes for the design and construction of vaccines for a range of medically important human diseases. The company was founded by J. Robert Coleman, Eckard Wimmer, Charlie Petty and Steffen Mueller in 2009 and is headquartered in Farmingdale, NY.

Celmatix, Inc. operates as a personalized medicine company that focuses on women?s health. It offers POLARIS, a web-based analytics platform for optimizing a woman?s fertility; and NOVA, a patient portal that helps clinics to maximize the patient experience. Its products help women to make informed decisions about their fertility, as well as provide doctors with data-driven tools for patient care. The company was founded by Piraye Yurttas Beim and Laura Towart Bandak in 2009 and is headquartered New York, NY.

DepYmed , Inc. is a cancer and rare disease therapeutic development company. The company is headquartered in Farmingdale, NY.

Celmatix, Inc. operates as a personalized medicine company that focuses on women?s health. It offers POLARIS, a web-based analytics platform for optimizing a woman?s fertility; and NOVA, a patient portal that helps clinics to maximize the patient experience. Its products help women to make informed decisions about their fertility, as well as provide doctors with data-driven tools for patient care. The company was founded by Piraye Yurttas Beim and Laura Towart Bandak in 2009 and is headquartered New York, NY.

Accelerate Long Island, Inc. engages in the collaboration of research institutions and business communities. The company was founded in 2011 and is headquartered in Melville, NY.

Celmatix, Inc. operates as a personalized medicine company that focuses on women?s health. It offers POLARIS, a web-based analytics platform for optimizing a woman?s fertility; and NOVA, a patient portal that helps clinics to maximize the patient experience. Its products help women to make informed decisions about their fertility, as well as provide doctors with data-driven tools for patient care. The company was founded by Piraye Yurttas Beim and Laura Towart Bandak in 2009 and is headquartered New York, NY.

GenDx, Inc. provides healthcare services. The private company is based in New York, NY.

ThermoLift, Inc. is a company that is based in Stony Brook, NY. The company is an affiliate of Stony Brook University's Clean Energy Business Incubator Program (CEBIP) and is headquartered at the Advanced Energy Research and Technology Center (AERTC). ThermoLift's engineering, development, and testing center is located in Livonia, NY. The company's TC3 has been ranked #1 in the DOE report "Energy Savings Potential and RD&D Opportunities for Commercial Building HVAC Systems." The DOE provided funding, and performance testing was conducted by Oak Ridge National Labs. The TC3 has received an agency field label approval for installation in buildings. It was founded in 2012 by Peter Hofbauer and Paul Schwartz, and the CEO is David Parks.

Accelerate Long Island, Inc. engages in the collaboration of research institutions and business communities. The company was founded in 2011 and is headquartered in Melville, NY.

DepYmed , Inc. is a cancer and rare disease therapeutic development company. The company is headquartered in Farmingdale, NY.

Celmatix, Inc. operates as a personalized medicine company that focuses on women?s health. It offers POLARIS, a web-based analytics platform for optimizing a woman?s fertility; and NOVA, a patient portal that helps clinics to maximize the patient experience. Its products help women to make informed decisions about their fertility, as well as provide doctors with data-driven tools for patient care. The company was founded by Piraye Yurttas Beim and Laura Towart Bandak in 2009 and is headquartered New York, NY.

Accelerate Long Island, Inc. engages in the collaboration of research institutions and business communities. The company was founded in 2011 and is headquartered in Melville, NY.

SetPoint Medical Corp. operates as a biomedical technology company, which engages in the development of therapies for patients with inflammatory autoimmune diseases such as rheumatoid arthritis and Crohn?s disease. The company was founded by Kevin J. Tracey, Shaw H. Warren, and James W. Broderick in 2006 and is headquartered in Santa Clarita, CA.

ThermoLift, Inc. is a company that is based in Stony Brook, NY. The company is an affiliate of Stony Brook University's Clean Energy Business Incubator Program (CEBIP) and is headquartered at the Advanced Energy Research and Technology Center (AERTC). ThermoLift's engineering, development, and testing center is located in Livonia, NY. The company's TC3 has been ranked #1 in the DOE report "Energy Savings Potential and RD&D Opportunities for Commercial Building HVAC Systems." The DOE provided funding, and performance testing was conducted by Oak Ridge National Labs. The TC3 has received an agency field label approval for installation in buildings. It was founded in 2012 by Peter Hofbauer and Paul Schwartz, and the CEO is David Parks.

Codagenix, Inc. provides platform technology to construct viral vaccines against multiple targets. It focuses on SAVE platform technology that utilizes computer-based rational design of viral genomes for the design and construction of vaccines for a range of medically important human diseases. The company was founded by J. Robert Coleman, Eckard Wimmer, Charlie Petty and Steffen Mueller in 2009 and is headquartered in Farmingdale, NY.

Mirimus, Inc. is a private company based in Brooklyn, NY that specializes in creating animal models for preclinical evaluation of new therapeutics. The company uses rnai and crispr technologies to develop these models and have established themselves as a leader in conducting high-volume, complex and highly effective pcr testing. Mirimus has developed SalivaClear, a COVID-19 testing platform that combines saliva-based sampling, pooled testing, and pcr diagnostics to improve the scalability, efficiency, cost-effectiveness, and accuracy of COVID-19 testing. The company was founded in 2010 by Stephen Elledge, Prem Premsrirut, Lukas Dow, Christof Fellman, Greg Hannon, Scott W. Lowe, Johannes Zuber, and Prem Premsrirut has been the CEO since 2010.

Codagenix, Inc. provides platform technology to construct viral vaccines against multiple targets. It focuses on SAVE platform technology that utilizes computer-based rational design of viral genomes for the design and construction of vaccines for a range of medically important human diseases. The company was founded by J. Robert Coleman, Eckard Wimmer, Charlie Petty and Steffen Mueller in 2009 and is headquartered in Farmingdale, NY.

Codagenix, Inc. provides platform technology to construct viral vaccines against multiple targets. It focuses on SAVE platform technology that utilizes computer-based rational design of viral genomes for the design and construction of vaccines for a range of medically important human diseases. The company was founded by J. Robert Coleman, Eckard Wimmer, Charlie Petty and Steffen Mueller in 2009 and is headquartered in Farmingdale, NY.

Accelerate Long Island, Inc. engages in the collaboration of research institutions and business communities. The company was founded in 2011 and is headquartered in Melville, NY.

ThermoLift, Inc. is a company that is based in Stony Brook, NY. The company is an affiliate of Stony Brook University's Clean Energy Business Incubator Program (CEBIP) and is headquartered at the Advanced Energy Research and Technology Center (AERTC). ThermoLift's engineering, development, and testing center is located in Livonia, NY. The company's TC3 has been ranked #1 in the DOE report "Energy Savings Potential and RD&D Opportunities for Commercial Building HVAC Systems." The DOE provided funding, and performance testing was conducted by Oak Ridge National Labs. The TC3 has received an agency field label approval for installation in buildings. It was founded in 2012 by Peter Hofbauer and Paul Schwartz, and the CEO is David Parks.

SetPoint Medical Corp. operates as a biomedical technology company, which engages in the development of therapies for patients with inflammatory autoimmune diseases such as rheumatoid arthritis and Crohn?s disease. The company was founded by Kevin J. Tracey, Shaw H. Warren, and James W. Broderick in 2006 and is headquartered in Santa Clarita, CA.

Accelerate Long Island, Inc. engages in the collaboration of research institutions and business communities. The company was founded in 2011 and is headquartered in Melville, NY.

Accelerate Long Island, Inc. engages in the collaboration of research institutions and business communities. The company was founded in 2011 and is headquartered in Melville, NY.

Accelerate Long Island, Inc. engages in the collaboration of research institutions and business communities. The company was founded in 2011 and is headquartered in Melville, NY.

SetPoint Medical Corp. operates as a biomedical technology company, which engages in the development of therapies for patients with inflammatory autoimmune diseases such as rheumatoid arthritis and Crohn?s disease. The company was founded by Kevin J. Tracey, Shaw H. Warren, and James W. Broderick in 2006 and is headquartered in Santa Clarita, CA.

SetPoint Medical Corp. operates as a biomedical technology company, which engages in the development of therapies for patients with inflammatory autoimmune diseases such as rheumatoid arthritis and Crohn?s disease. The company was founded by Kevin J. Tracey, Shaw H. Warren, and James W. Broderick in 2006 and is headquartered in Santa Clarita, CA.

Accelerate Long Island, Inc. engages in the collaboration of research institutions and business communities. The company was founded in 2011 and is headquartered in Melville, NY.

Accelerate Long Island, Inc. engages in the collaboration of research institutions and business communities. The company was founded in 2011 and is headquartered in Melville, NY.

ThermoLift, Inc. is a company that is based in Stony Brook, NY. The company is an affiliate of Stony Brook University's Clean Energy Business Incubator Program (CEBIP) and is headquartered at the Advanced Energy Research and Technology Center (AERTC). ThermoLift's engineering, development, and testing center is located in Livonia, NY. The company's TC3 has been ranked #1 in the DOE report "Energy Savings Potential and RD&D Opportunities for Commercial Building HVAC Systems." The DOE provided funding, and performance testing was conducted by Oak Ridge National Labs. The TC3 has received an agency field label approval for installation in buildings. It was founded in 2012 by Peter Hofbauer and Paul Schwartz, and the CEO is David Parks.

Codagenix, Inc. provides platform technology to construct viral vaccines against multiple targets. It focuses on SAVE platform technology that utilizes computer-based rational design of viral genomes for the design and construction of vaccines for a range of medically important human diseases. The company was founded by J. Robert Coleman, Eckard Wimmer, Charlie Petty and Steffen Mueller in 2009 and is headquartered in Farmingdale, NY.

Accelerate Long Island, Inc. engages in the collaboration of research institutions and business communities. The company was founded in 2011 and is headquartered in Melville, NY.

GenDx, Inc. provides healthcare services. The private company is based in New York, NY.

Accelerate Long Island, Inc. engages in the collaboration of research institutions and business communities. The company was founded in 2011 and is headquartered in Melville, NY.

DepYmed , Inc. is a cancer and rare disease therapeutic development company. The company is headquartered in Farmingdale, NY.

SetPoint Medical Corp. operates as a biomedical technology company, which engages in the development of therapies for patients with inflammatory autoimmune diseases such as rheumatoid arthritis and Crohn?s disease. The company was founded by Kevin J. Tracey, Shaw H. Warren, and James W. Broderick in 2006 and is headquartered in Santa Clarita, CA.

Celmatix, Inc. operates as a personalized medicine company that focuses on women?s health. It offers POLARIS, a web-based analytics platform for optimizing a woman?s fertility; and NOVA, a patient portal that helps clinics to maximize the patient experience. Its products help women to make informed decisions about their fertility, as well as provide doctors with data-driven tools for patient care. The company was founded by Piraye Yurttas Beim and Laura Towart Bandak in 2009 and is headquartered New York, NY.

DepYmed , Inc. is a cancer and rare disease therapeutic development company. The company is headquartered in Farmingdale, NY.

SetPoint Medical Corp. operates as a biomedical technology company, which engages in the development of therapies for patients with inflammatory autoimmune diseases such as rheumatoid arthritis and Crohn?s disease. The company was founded by Kevin J. Tracey, Shaw H. Warren, and James W. Broderick in 2006 and is headquartered in Santa Clarita, CA.

Accelerate Long Island, Inc. engages in the collaboration of research institutions and business communities. The company was founded in 2011 and is headquartered in Melville, NY.

Accelerate Long Island, Inc. engages in the collaboration of research institutions and business communities. The company was founded in 2011 and is headquartered in Melville, NY.

Celmatix, Inc. operates as a personalized medicine company that focuses on women?s health. It offers POLARIS, a web-based analytics platform for optimizing a woman?s fertility; and NOVA, a patient portal that helps clinics to maximize the patient experience. Its products help women to make informed decisions about their fertility, as well as provide doctors with data-driven tools for patient care. The company was founded by Piraye Yurttas Beim and Laura Towart Bandak in 2009 and is headquartered New York, NY.

Accelerate Long Island, Inc. engages in the collaboration of research institutions and business communities. The company was founded in 2011 and is headquartered in Melville, NY.

SetPoint Medical Corp. operates as a biomedical technology company, which engages in the development of therapies for patients with inflammatory autoimmune diseases such as rheumatoid arthritis and Crohn?s disease. The company was founded by Kevin J. Tracey, Shaw H. Warren, and James W. Broderick in 2006 and is headquartered in Santa Clarita, CA.

SetPoint Medical Corp. operates as a biomedical technology company, which engages in the development of therapies for patients with inflammatory autoimmune diseases such as rheumatoid arthritis and Crohn?s disease. The company was founded by Kevin J. Tracey, Shaw H. Warren, and James W. Broderick in 2006 and is headquartered in Santa Clarita, CA.

Celmatix, Inc. operates as a personalized medicine company that focuses on women?s health. It offers POLARIS, a web-based analytics platform for optimizing a woman?s fertility; and NOVA, a patient portal that helps clinics to maximize the patient experience. Its products help women to make informed decisions about their fertility, as well as provide doctors with data-driven tools for patient care. The company was founded by Piraye Yurttas Beim and Laura Towart Bandak in 2009 and is headquartered New York, NY.

Accelerate Long Island, Inc. engages in the collaboration of research institutions and business communities. The company was founded in 2011 and is headquartered in Melville, NY.

Codagenix, Inc. provides platform technology to construct viral vaccines against multiple targets. It focuses on SAVE platform technology that utilizes computer-based rational design of viral genomes for the design and construction of vaccines for a range of medically important human diseases. The company was founded by J. Robert Coleman, Eckard Wimmer, Charlie Petty and Steffen Mueller in 2009 and is headquartered in Farmingdale, NY.